| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |